治疗抵抗性精神分裂症（TRS）的概念与管理。
Concept and Management of Treatment Resistant Schizophrenia (TRS).
机构信息
Senior Resident, Dept. of Psychiatry, PGIMER, Chandigarh - 160 012, India.
出版信息
Indian J Psychiatry. 2004 Apr;46(2):125-34.
Abstract
Treatment resistance in schizophrenia is a fairly common problem faced by psychiatrists worldwide. The concept and definition of Treatment Resistant Schizophrenia (TRS) is still far from satisfactory. Data suggests the presence of biological factors underlying TRS. Second generation antipsychotics are advocated for patients with TRS. However, till date, clozapine remains the treatment of choice. Evidence for other pharmacological measures and ECT is accumulating. Psychosocial interventions do form an integral component of management of TRS. It can be concluded that, with advances in sychopharmacology, TRS needs to be better researched and managed in the future.
摘要
精神分裂症的治疗抵抗是全世界精神科医生面临的一个相当常见的问题。治疗抵抗性精神分裂症（TRS）的概念和定义仍远不能令人满意。数据表明，TRS 存在生物学因素。第二代抗精神病药被推荐用于 TRS 患者。然而，迄今为止，氯氮平仍然是治疗的首选。其他药物治疗措施和电惊厥治疗的证据也在不断增加。心理社会干预确实是 TRS 管理的一个组成部分。可以得出结论，随着精神药理学的进步，未来需要更好地研究和管理 TRS。
相似文献
1
Concept and Management of Treatment Resistant Schizophrenia (TRS).治疗抵抗性精神分裂症（TRS）的概念与管理。
Indian J Psychiatry. 2004 Apr;46(2):125-34.
2
Clozapine in Treatment-Resistant Schizophrenia and Its Augmentation with Electroconvulsive Therapy in Ultra-Treatment-Resistant Schizophrenia.氯氮平治疗难治性精神分裂症及其联合电休克治疗超难治性精神分裂症
Biomedicines. 2023 Apr 2;11(4):1072. doi: 10.3390/biomedicines11041072.
3
Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.治疗抵抗性精神分裂症患者的特征、负担和药物治疗：来自对 204 名美国精神科医生的调查结果。
BMC Psychiatry. 2019 Nov 14;19(1):362. doi: 10.1186/s12888-019-2318-x.
4
Treatment resistant schizophrenia: Clinical, biological, and therapeutic perspectives.治疗抵抗性精神分裂症：临床、生物学和治疗学视角。
Neurobiol Dis. 2019 Nov;131:104257. doi: 10.1016/j.nbd.2018.08.016. Epub 2018 Aug 29.
5
Commentary on Braga et al: The Potential of Large Simple Trials to Determine the Real-World Effectiveness of Combined Electroconvulsive Therapy and Antipsychotics in Treating Patients With Treatment-Resistant Schizophrenia.布雷加等人的述评：大样本简单试验在确定电抽搐治疗联合抗精神病药物治疗治疗抵抗性精神分裂症患者的真实世界疗效方面的潜力。
J ECT. 2019 Sep;35(3):153-155. doi: 10.1097/YCT.0000000000000584.
6
Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis.伴有或不伴有治疗抵抗的精神分裂症的抗精神病药物治疗的异质性和疗效：一项荟萃分析。
Neuropsychopharmacology. 2020 Mar;45(4):622-631. doi: 10.1038/s41386-019-0577-3. Epub 2019 Nov 25.
7
Treatment-Resistant Schizophrenia: Definition, Predictors, and Therapy Options.治疗抵抗性精神分裂症：定义、预测因素和治疗选择。
J Clin Psychiatry. 2021 Sep 7;82(5):MY20096AH1C. doi: 10.4088/JCP.MY20096AH1C.
8
Young patient with treatment-resistant schizophrenia drastically improved by combination of clozapine and maintenance electroconvulsive therapy: a case report.氯氮平与维持性电休克治疗联合使用使难治性精神分裂症年轻患者病情大幅改善：一例报告
Int Med Case Rep J. 2019 Jun 21;12:185-188. doi: 10.2147/IMCRJ.S198124. eCollection 2019.
9
Schizophrenia: when clozapine fails.精神分裂症：氯氮平治疗失败时。
Curr Opin Psychiatry. 2015 May;28(3):243-8. doi: 10.1097/YCO.0000000000000159.
10
Treatment-resistant schizophrenia: challenges and implications for clinical practice.难治性精神分裂症：临床实践面临的挑战与影响
Psychiatr Danub. 2015 Sep;27(3):319-26.
引用本文的文献
1
Achieving stable remission with maintenance electroconvulsive therapy in a patient with treatment-resistant schizophrenia: A case report.通过维持性电休克治疗使难治性精神分裂症患者实现稳定缓解：一例病例报告。
Medicine (Baltimore). 2017 Dec;96(48):e8813. doi: 10.1097/MD.0000000000008813.
本文引用的文献
1
Efficacy of Electroconvulsive Therapy in Treatment Resistant Schizophreinia : A double-blind study.电抽搐治疗对难治性精神分裂症的疗效：一项双盲研究。
Indian J Psychiatry. 2003 Jan;45(1):26-9.
2
Predictors of clinical outcome in schizophrenic patients responding to clozapine.对氯氮平有反应的精神分裂症患者临床结局的预测因素
J Clin Psychopharmacol. 2003 Dec;23(6):660-4. doi: 10.1097/01.jcp.0000095351.32154.3a.
3
Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia.与难治性精神分裂症中氯氮平反应相关的大脑解剖学和功能变量。
Psychiatry Res. 2003 Nov 30;124(3):153-61. doi: 10.1016/s0925-4927(03)00108-2.
4
Clozapine v. conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination.
Br J Psychiatry. 2003 Aug;183:161-6. doi: 10.1192/bjp.183.2.161.
5
Tolerability and efficacy of clozapine combined with lithium in schizophrenia and schizoaffective disorder.
J Clin Psychopharmacol. 2003 Jun;23(3):223-8. doi: 10.1097/01.jcp.0000084026.22282.5f.
6
Antiepileptic drugs in schizophrenia: a review.抗癫痫药物在精神分裂症中的应用：综述
Eur Psychiatry. 2002 Nov;17(7):371-8. doi: 10.1016/s0924-9338(02)00696-x.
7
Benzodiazepines in schizophrenia: prefrontal cortex atrophy predicts clinical response to alprazolam augmentation.
World J Biol Psychiatry. 2002 Oct;3(4):221-4. doi: 10.3109/15622970209150625.
8
9
Carbamazepine augmentation for schizophrenia: how good is the evidence?卡马西平增效治疗精神分裂症：证据有多可靠？
J Clin Psychiatry. 2002 Mar;63(3):218-24. doi: 10.4088/jcp.v63n0308.
10
Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome study.使用拉莫三嗪或托吡酯增强难治性精神分裂症患者的抗精神病药物治疗：一项自然主义病例系列结局研究。
J Psychopharmacol. 2001 Dec;15(4):297-301. doi: 10.1177/026988110101500409.
Zotero 插件